Silica Nanoparticle Applications in Biomedicine

Silica nanoparticles of between 1 – 100 nm in diameter are cost-effective and simple to produce, with a highly modifiable surface chemistry, shape, and size. They commonly act as a support scaffold or coating for biomolecules or other nanoparticles and potentially make excellent drug delivery platforms due to their highly biocompatible nature and porous structure.

3d illustration of mesoporous silica nanoparticles delivering drug to cells. Image Credit: Meletios Verras / Shutterstock
3d illustration of mesoporous silica nanoparticles delivering drug to cells. Image Credit: Meletios Verras / Shutterstock

Biocompatibility

Silica is frequently used as an inert, non-toxic coating for other types of the nanoparticle, which is biodegradable within a reasonable timescale, ensuring a minimal level of bioaccumulation. These other nanoparticles may be acting as contrast agents or radiation dose enhancers, among other functions, and may be made from gold, silver, iron oxide, polymers, or other materials. A silica coating protects these materials from interaction with biomolecules present in a biological medium that may induce early excretion, or prevent the nanoparticle from completing its intended function. Additionally, a silica coating presents an easily customizable surface chemistry for the attachment of targeting molecules.

Silica Nanoparticle

Surface Chemistry

Silica nanoparticles present an exposed hydroxyl group at their surface which allows for conjugation with various molecules. The attachment of molecules to the surface of silica nanoparticles usually takes place through post-synthetic grafting, where a molecule able to bond with silica’s silanol group is added after the particle is already formed. Another method, co-condensation, incorporates the molecule to be attached into the synthesis of silica nanoparticles, ensuring a complete coating on both the exposed surface and internal porous area.

Targeting biomolecules such as polysaccharide chains, antibodies, DNA, other types of proteins or novel molecules can be attached to the surface of the nanoparticle, encouraging them to locate and enter specific tissues and cells within the body.

The surface chemistry of silica nanoparticles also provides applications in biosensing both in vitro and in vivo. DNA can be detected, separated, and purified easily using silica nanoparticles through electrostatic, hydrophobic, and hydrogen bonding interactions that take place between them.

Porous Structure

Silica nanoparticles are highly porous, providing a large protected internal surface area on which drugs can be bound for delivery. Other materials, such as cadmium sulfide, are used to block the entrance to these pores until chemically triggered to open when in the target drug delivery location.

Stabilizer

Silica is used as a stabilizer due to its ability to absorb water, thanks to the presence of polar hydroxyl groups attached to silicon molecules at the surface of the material, and the high surface area of the silica nanoparticle. Silica is incorporated into medicines for this purpose, with aspirin tablets often containing an optimum of 3% silica. Silica nanoparticles are also used as a glidant, added to medicines when in powder form to improve the ability to pour and shape the powder before compression into a tablet.

Bactericidal and Viricidal Agents

Silica nanoparticles may play a direct or supporting role in the development of nanomedicines intended to destroy bacteria or viruses.

Positively charged silica particles have been shown to accumulate near the cell wall of bacteria, due to the slightly negative charge that bacteria possess. The comparatively simple cell surface of bacteria compared with mammalian cells, consisting largely of lipopolysaccharide chains, allows hydrogen bonds to form with the silanol groups of silica, drawing the particles into the bacteria. The lower pH of the lysosomal compartment within the bacterium is then able to trigger the simultaneous release of potentially a variety of antibiotic drugs directly into the bacterium, lowering the opportunity for it to develop resistance by gradual exposure.

Current antiviral drugs are limited by poor solubility in water, low retention time in the body, and slow uptake throughout the body where they are needed. These shortcomings can be improved by incorporation with silica nanoparticles as delivery vehicles, improving biodistribution throughout the body and increasing the probability of entering currently infected cells to deliver a payload of viricidal agents.

Sources

Further Reading

Last Updated: Oct 17, 2018

Michael Greenwood

Written by

Michael Greenwood

Michael graduated from the University of Salford with a Ph.D. in Biochemistry in 2023, and has keen research interests towards nanotechnology and its application to biological systems. Michael has written on a wide range of science communication and news topics within the life sciences and related fields since 2019, and engages extensively with current developments in journal publications.  

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Greenwood, Michael. (2018, October 17). Silica Nanoparticle Applications in Biomedicine. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/life-sciences/Silica-Nanoparticle-Applications-in-Biomedicine.aspx.

  • MLA

    Greenwood, Michael. "Silica Nanoparticle Applications in Biomedicine". News-Medical. 31 October 2024. <https://www.news-medical.net/life-sciences/Silica-Nanoparticle-Applications-in-Biomedicine.aspx>.

  • Chicago

    Greenwood, Michael. "Silica Nanoparticle Applications in Biomedicine". News-Medical. https://www.news-medical.net/life-sciences/Silica-Nanoparticle-Applications-in-Biomedicine.aspx. (accessed October 31, 2024).

  • Harvard

    Greenwood, Michael. 2018. Silica Nanoparticle Applications in Biomedicine. News-Medical, viewed 31 October 2024, https://www.news-medical.net/life-sciences/Silica-Nanoparticle-Applications-in-Biomedicine.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
mRNA therapy shows promise for maple syrup urine disease